Parents Speak Out After 12-Year-Old Son Dies from Brain-Eating Amoeba: 'We Don't Want His Death to Be in Vain'
Jaysen Carr, 12, died July 18 from Naeglaria fowleri, a brain-eating amoeba that thrives in warm freshwater
His parents said they were unaware that it lived in Lake Murray, where Jaysen swam and engaged in other water activities over the Fourth of July weekend
According to the Centers for Disease Control and Prevention, the amoeba is rarely contracted, but nearly always fatalThe parents of a 12-year-old boy who died this month from a brain-eating amoeba at a popular lake in South Carolina say they want warnings to be put in place to prevent similar tragedies.
Clarence and Ebony Carr of Columbia, South Carolina, said they were unaware brain-eating amoeba, Naeglaria fowleri, lived in Lake Murray, where their son, Jaysen, spent time fishing, swimming, boating and tubing over the Fourth of July weekend.
Jaysen died on July 18 after being hospitalized for a week and a half from the amoeba, which has killed 163 people between 1962 and 2024 in the U.S., according to the Centers for Disease Control and Prevention.
Prisma Health Children's Hospital in South Carolina confirmed that Jaysen died from Naeglaria fowleri.
"We're still in shock about how all this happened," Ebony said at a news conference Tuesday, where she and her husband spoke publicly for the first time since their son's death. "Had he known the risk, had we known the risk of him swimming in that lake, nobody would have ever chosen to get in."
"We definitely want the public to know that there are major risks swimming in Lake Murray," Ebony said. "There needs to definitely be some awareness about it, and we don't want his death to be in vain, because had we known, he wouldn't have been in it."
Dominion Energy, which owns the lake, did not immediately return a request for comment.
"A child should not have to lose their life for doing something they assume was safe," Clarence said. "They should not have to double-check to see if they are going to live or die from being a boy. He had a weekend full of fishing, swimming, boating, tubing. That's it. That's all he did."
Clarence said a few days after the visit to Lake Murray, Jaysen complained of a headache. His parents gave him over-the-counter pain medicine, which seemed to make him feel better.
But the next day, Jaysen complained of the same headache, so they took him to the hospital. There, Jaysen told emergency room doctors where exactly he felt pain — on the right side and front of his head and in his left eye.
"In hindsight, 2020, this was no headache. He was being attacked," Clarence said, adding that doctors put Jaysen on antibiotics and performed a spinal tap to rule out meningitis.
"From there, things just kind of progressively got worse," he said. "Jaysen was still responding, but he became more and more lethargic as time went on."
According to the CDC, Naeglaria fowleri lives in soil and warm freshwater lakes, rivers, ponds, and hot springs. If water containing the amoeba goes up the nose and to the brain, it can cause an infection called primary amebic meningoencephalitis, which destroys brain tissue and causes brain swelling and death. Typically, fewer than 10 people get it a year in the U.S., and nearly all of them die, the CDC says.
Jaysen exhibited some of the early symptoms of the infection, which include headache, fever, nausea and vomiting.
At the hospital briefing, Anna-Kathryn Burch, a doctor of pediatric infectious diseases, said the amoeba is 'ubiquitous to any fresh water in the state of South Carolina' and in the Southeastern part of the country. For most people who come into contact with this type of amoeba, she said, "it causes no harm whatsoever."
As the weather heats up, the number of amoeba in the water increases while water levels decrease, Burch said, adding, 'Most of us have been exposed to this amoeba."
Jaysen was the couple's middle child and was very protective of his older sister and younger brother.
"He truly had the gift of love, compassion, the athleticism and that big smile that everybody loved about him," Ebony said.
A bright student, Jaysen skipped a grade in school, his father said, and played baseball and football, as well as multiple instruments, and was a member of his school's honor band.
"I never heard Jaysen say he liked someone," Clarence said. "He either loved you or he just simply did not know who you were."
According to the CDC, Naegleria fowleri infections are most often contracted by swimming, but can also occur if a person uses contaminated drinking water to cleanse their nasal passages. The CDC says the only way to prevent an infection is to avoid water-related activities in warm freshwater. If you do swim in rivers or lakes, the CDC advises, hold your nose shut, use nose clips or keep your head above water
In a statement to PEOPLE, the South Carolina Department of Environmental Services said:
Neither the U.S. Environmental Protection Agency (EPA) nor the U.S. Centers for Disease Control and Prevention (CDC) recommend the routine sampling of ambient water for Naegleria fowleri. We're not aware of any states that perform routine sampling of ambient water for this amoeba. The CDC doesn't recommend testing untreated recreational water or posting signage for Naeglaria fowleri because the location and number of amebas can vary over time within the same body of water, there are no standardized testing methods to detect and determine the number of Naegleria fowleri in the water. and people might mistakenly think that water without signs is free of Naegleria fowleri.
The agency said it "monitors ambient water bodies for certain bacteria that have federal and state recreational water standards," noting that such standards do not exist for Naeglaria fowleri .
Read the original article on People
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Fox News
24 minutes ago
- Fox News
Doctor urges parents to take 'digital pacifiers' away from children
'The Anxious Generation' author Dr. Jonathan Haidt describes the impact of smartphones on Gen Z's mental health and reveals 'nature's recipe' for growing up on 'Fox & Friends Weekend.'
Yahoo
an hour ago
- Yahoo
Should You Take a Vitamin B12 Supplement?
Credit - Photo-Illustration by TIME (Source Images: eyenigelen/Getty Images, Sersol/Getty Images) Everyone needs vitamin B12: It helps the body produce red blood cells and maintain healthy brain function, along with so many other things. But are you getting enough of it? Here's what to know about vitamin B12 and whether you should consider upping your levels. A boon for brain health 'Vitamin B12 is important for brain health because it helps protect nerve cells in the brain, which support memory and thinking skills,' says Michelle Routhenstein, a preventive cardiology dietitian and certified diabetes educator in New York. It's water-soluble, so the body does not store it in large amounts, and daily intake is essential. The current federal recommendations are for adults to get 2.4 mcg of vitamin B12 per day. Great food sources of B12 include seafood like oysters, salmon and tuna, beef, and fortified products like nutritional yeast, plant-based milks, some breads and breakfast cereals, says Routhenstein. But some recent research suggests that some people may need even more than that. Vitamin B12 deficiencies can impact your brain function even when your intake levels are considered normal, says Dr. Ari J. Green, a professor at the University of California, San Francisco's department of ophthalmology. In a recent study, Green and his colleagues found that people with B12 levels that were technically normal but on the lower end of the range had impaired brain function. 'We could detect neurological impairment at levels currently considered 'normal,' independently of other factors like years of education," particularly in older people, says Dr. Alexandra Beaudry-Richard, a resident at McGill University and co-author of the study. 'To us, this should reinvigorate a conversation about how much B12 is needed for optimal neurological function.' Read More: Should You Take a Vitamin D Supplement? Other studies have found that people with Alzheimer's disease and mild cognitive impairment tend to have lower B12 levels—and supplementation with B12 can reduce the rate of brain atrophy. However, on the opposite end, the study showed signs of a possible detrimental effect on the brain when people had high B12 levels in their blood. 'This warrants further studies to evaluate what healthy B12 levels are on both ends of the spectrum,' says Dr. Ahmed Abdelhak, one of the study's authors and a clinical instructor in neurology at UCSF School of Medicine. Should you take a B12 supplement? You can (and should) get B12 from your diet, but some people may have a tough time getting adequate levels of the nutrient from food alone. Older adults are more likely to develop vitamin B12 deficiencies because the vitamin requires stomach acid to be absorbed, and stomach acid production starts to decline with age. Routhenstein recommends people look closer into their B12 status starting around age 50 or if they are at higher risk of a B12 deficiency. This category includes vegans and vegetarians, people taking specific medications that interfere with B12 absorption such as metformin or proton pump inhibitors, and those who have gastrointestinal disorders like Crohn's, celiac, or atrophic gastritis. You can get tested for a vitamin B12 deficiency at your annual physical. If you are deficient, your doctor might recommend supplementation. Read More: 7 Surprising Symptoms of Lyme Disease The UCSF study authors recommend checking levels starting at age 70, but you can get it checked on a standard blood test at any age through your primary care physician. Dr. Ralph Green, a professor of pathology and lab medicine at the University of California, Davis—and another author on that recent study—says that checking B12 may also be valuable for people who have unexplained symptoms that have been linked to B12 deficiency. For those with declining gastric function, he says taking supplements is likely the best way to promote absorption, and the level of supplementation a person should consume depends on whether their absorption is normal or not. Pregnant women, too, need higher B12 intake to support fetal brain development; if you're pregnant, consult with your ob-gyn about optimal B12 levels for you. What kind of B12 supplement is best? B12 in supplements and fortified foods can be more easily absorbed than from food, especially for older adults and those with absorption issues, says Routhenstein. If your doctor has advised you to take a B12 supplement, it's best to ask them to recommend specific dosages and brands. But Routhenstein recommends following these general guidelines when selecting a B12 supplement. Always look for those with methylcobalamin on the label, as this is the most bioavailable form of B12, meaning the body can absorb it the best. It's also the optimal form for heart and brain health and nerve function, she says. Sublingual (under the tongue) or liquid B12 is often touted for better absorption. This form of B12 does so 'by bypassing the digestive system and entering the bloodstream directly,' says Routhenstein. Of course, no supplement is a cure-all, and there are other ways to support brain health, including maintaining a healthy diet and exercise regimen. Activities that stimulate multiple brain areas simultaneously are excellent at promoting cognitive longevity, Beaudry-Richard says. Practicing a musical instrument, dancing, and studying a foreign language daily, for example, all recruit 'brain circuits responsible for vision, hearing, movement, emotions' and more. 'It's like a full-body workout for the brain,' she says. Contact us at letters@
Yahoo
an hour ago
- Yahoo
Viking's Oral Obesity Drug Poised To Gain Ground After Eli Lilly's Orforglipron Setback: Analyst
Viking Therapeutics, Inc. (NASDAQ:VKTX) is pressing ahead in the weight-loss drug race with the launch of its Phase 2 VENTURE-Oral trial to test a daily pill version of VK2735 in obese and overweight adults, a move analysts say could position the company to capitalize on Eli Lilly's recent setback and expand treatment options beyond injections. The study, which began in January 2025, will assess the safety, tolerability, pharmacokinetics and weight-loss efficacy of once-daily oral dosing over a 13-week period. VK2375 is being developed in oral and subcutaneous formulations. The target population consists of adults with obesity (BMI ≥30 kg/m2) or who are overweight (BMI ≥27 kg/m2) with at least one weight-related co-morbid study's primary endpoint is the percent change in body weight from baseline after 13 weeks of treatment. Secondary and exploratory endpoints will evaluate additional safety and efficacy measures. Viking expects to release results in the second half of 2025, with William Blair projecting an August readout. Analyst Andy Hsieh wrote Tuesday, 'Our base-case expectation is to replicate the 4-week Phase I results, translating to a placebo-adjusted weight loss of slightly under 7% for the highest doses.' Hsieh highlighted the advantage of using the same active ingredient across oral and injectable formats, allowing patients to switch between the two without increasing the risk of new side effects. William Blair reiterated its Outperform rating on Viking shares. Given the underwhelming weight loss magnitude from Eli Lilly and Co.'s (NYSE:LLY) Phase 3 ATTAIN-1 trial of orforglipron, coupled with potential uncertainties associated with the persistent rate of adverse events, the analyst believes the setback creates a clinical void for smaller competitors to fill. 'We expect Viking to rise to the occasion and demonstrate the potential of the oral tablet formulation of VK2735 as a competitive option in the maintenance setting. We therefore would be buyers before the Phase II VENTURE-oral readout,' William Blair wrote in an investor note on Tuesday. In June, Viking Therapeutics initiated the VANQUISH Phase 3 clinical program for subcutaneous VK2735. In 2024, Viking announced topline results from the Phase 2 VENTURE study of subcutaneous VK2735 in obesity. Patients receiving VK2735 demonstrated statistically significant reductions in mean body weight from baseline, ranging up to 14.7%, and statistically significant reductions in mean body weight relative to placebo, ranging up to 13.1%. Price Action: VKTX stock is trading higher by 2.38% to $40.81 at last check Wednesday. Read Next:Image via Shutterstock Latest Ratings for VKTX Date Firm Action From To Feb 2022 Raymond James Maintains Outperform Jul 2021 Raymond James Maintains Outperform May 2021 Raymond James Downgrades Strong Buy Outperform View More Analyst Ratings for VKTX View the Latest Analyst Ratings Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Viking's Oral Obesity Drug Poised To Gain Ground After Eli Lilly's Orforglipron Setback: Analyst originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data